期刊文献+

Bioactive peptides on endothelial function 被引量:1

下载PDF
导出
摘要 Cardiovascular diseases(CVD)such as myocardial infarction and stroke are a major cause of morbidity and mortality worldwide.Impairment of the normal vasorelaxant functions of the vascular endothelium,termed endothelial dysfunction;appear to underlie the pathogenesis of CVD.Endothelial dysfunction is often secondary to abnormal increases in oxidative stress,inflammation and overactivity of the renin–angiotensin system(RAS),which makes these pathways attractive targets for therapeutic interventions.Given the side-effects associated with synthetic pharmaceutical agents,there is growing interest in using natural products such as bioactive peptides for treating chronic diseases like CVD.In this review,we discuss the potential for bioactive peptides with antioxidant,anti-inflammatory and RAS modulating properties for treating endothelial dysfunction and preventing CVD.
出处 《Food Science and Human Wellness》 SCIE 2016年第1期1-7,共7页 食品科学与人类健康(英文)
  • 相关文献

参考文献1

二级参考文献66

  • 1Jin HY. Song B, Oudit GY. Davidge ST. Yu HM. Jiang YY. Gao PJ. Zhu DL. Ning G. Kassiri Z. Penninger JM. Zhong rc. ACE2 deficiency enhances angiotensin II-mediated aortic profilin-l expression. intlammalion and peroxynilrite production. PLoS ONE. 2012. 7: e38502.
  • 2Sato T. Suzuki T. Watanabe H. Kadowaki A. Fukamizu A. Liu PP. Kimura A. Ito H. Penninger JM. Imai Y. Kuba K. Apelin is a positive regulator of ACE2 in failing hearts. J Clin Invest. 2013. 123: 5203-5211.
  • 3Schiffrin EL. Vascular remodeling in hypertension: mechanisms and treatment. Hypertension. 2012. 59: 367-374.
  • 4Patel VB. Bodiga S. Basu R. Das SK. Wang W. Wang Z. Lo J. Grant MB. Zhong J. Kassiri Z. Oudit GY. Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin llIATI receptor axis. Circ Res. 2012. I JO: 1322-1335.
  • 5Heeneman S. Sluimer JC, Daemen MJ. Angiotensin-converting enzyme and vascular remodeling. Circ Res. 2007.101: 441-454.
  • 6Song B. Jin H, Yu X. Zhang Z. Yu H. Ye J. Xu Y. Zhou T. Oudit GY. Ye JY. Chen C. Gao P. Zhu D. Penninger JM. Zhong rc. Angiotensin-converting enzyme 2 attenuates oxidative stress and VSMC proliferation via the JAK2/STAT3/S0CS3 and profilin-I/MAPK signaling pathways. Regul Pept, 2013.185: 44-51.
  • 7Schiffrin EL. Touyz RM. From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am 1 Physiol Heart Circ Physiol, 2004, 287: H435-446.
  • 8Zhong lC. Huang Y. Yung LM. Lau CW, Leung FP. Wong WT. Lin SG. Yu XV. The novel peptide apelin regulates intrarenal artery tone in diabetic mice. Regul Pept, 2007,144: 109-114.
  • 9Bodiga S. Zhong JC, Wang W. Basu R. Lo J. Liu GC, Guo D. Hol- land SM. Scholey JW. Penninger JM. Kassiri Z. Oudit GY. Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit. Cardiovasc Res. 2011.91: 151-161.
  • 10Zhong J. Guo D. Chen CB. Wang W. Schuster M. Loibner H. Penninger JM. Scholey JW. Kassiri Z. Oudit GY. Prevention of angiotensin II-mediated renal oxidative stress. inflammation and fibrosis by angiotensin-converting enzyme 2. Hypertension. 2011. 57: 314-322.

共引文献15

同被引文献3

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部